J clin oncol. 1993 11:1269–1275

Author: aizk

August undefined, 2024

WebMar 1, 2001 · Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial Intensified adjuvant chemotherapy had a positive impact on the DFS and OS of patients with high-risk extremity soft tissue sarcomas at a median follow-up of 59 months. WebJun 7, 2024 · Synovial sarcoma is a rare malignant tumor that generally requires a multidisciplinary therapeutic approach. In this study we report the experience of a single surgeon, evaluating surgical and oncological outcomes of the cases he treated through his 30 years carrier. Methods We enrolled patients treated surgically between 1988 and 2024.

An intergroup phase III randomized study of doxorubicin …

WebNov 1, 2004 · The unadjusted hazard ratio for the effect of NAC on disease-specific survival was 0.75 (95% CI: 0.45–1.2). Using the Cox proportional hazards model stratified by … WebJ Clin Oncol. 1993; 11: 1269-1275 Scopus (438) PubMed Crossref Google Scholar O’Bryan R.M. Luce J.K. Talley R.W. et al. Phase II evaluation of adriamycin in human neoplasia. Cancer. 1973; 32: 1-8 Scopus (318) PubMed Crossref Google Scholar Bramwell V. Mourisden H. Santoro A. et al. global coach download

Randomized comparison of doxorubicin alone versus

WebGoogle Scholar. Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, Parkinson DR: Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or … WebOct 10, 2006 · Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, Parkinson DR (1993) ... J Clin Oncol 11: 1269–1275. CAS Article Google Scholar Fata F, O'Reilly E, Ilson D, Pfister D, Leffel D ... WebFeb 1, 1999 · An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas J Clin Oncol 11: (1993) 1276-1285 Antman K, Crowley J, Balcerzak SP et al. boeing executive office administrator

Treatment of advanced soft-tissue sarcomas using a combined

Randomized comparison of doxorubicin alone versus ifosfamide …

WebMar 1, 2005 · Introduction. Soft tissue sarcomas (STS) are rare tumours of connective tissue. They account for ∼1% of all cancers worldwide each year. Synovial sarcoma represents ∼5–10% of all STS [].It affects young individuals, mostly within the range of 15–40 years of age. WebJ Clin Oncol. 1993;11(7):1269–1275. 41. Verma S, Younus J, Stys-Norman D, Haynes AE, Blackstein M; Members of the Sarcoma Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care. Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma. boeing evolutionWebAt Levine Cancer Institute, your well-being is always our top priority. From extensive cleaning protocols to coronavirus screenings for staff and patients, we’re doing everything we can … boeing executive council

"WebMar 5, 2014 · Whether doxorubicin alone or the combination of doxorubicin and ifosfamide should be used routinely is still controversial. We assessed whether dose intensification … " - J clin oncol. 1993 11:1269–1275

J clin oncol. 1993 11:1269–1275

Temozolomide post pazopanib treatment failure in patients with

WebEdmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, Parkinson DR: Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol 11: 1269–1275, 1993 Google Scholar WebFeb 28, 2014 · Merkel cell carcinoma (MCC) is a rare malignant tumor first described in 1972 by Toker [ 1 ]. MCC is an aggressive tumor of the skin that arises from neuroendocrine cells within the basal layer of the epidermis, affecting mainly sun-exposed areas with high tendency for metastatic disease [ 2 ]. Although the exact etiology remains unknown, viral ...

Did you know?

WebJ Clin Oncol 1993;11:1269-1275. Gottlieb JA, Baker LH, O’Bryan RM, et al, Adriamycin used alone and in combination for soft tissue and bony sarcomas. Cancer Chemother Rep, 1975; 6: 271-82. Pervaiz N, Colterjohn N, Farrokhyar F, et al. WebJ Clin Oncol 1993, 11 :1269–1275. PubMed CAS Google Scholar Baker LH, Frank J, Fine G, et al.: Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and …

WebJ Clin Oncol.1993;11:1276–1285. 4. Adjuvant chemotherapy for localized resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Sarcoma Meta-analysis … WebNov 15, 2024 · J Clin Oncol. 1993; 11(7): 1276–1285. pmid:8315425 . View Article ... and cisplatin against advanced soft tissue sarcomas. J Clin Oncol. 1993; 11(7): 1269–1275. pmid:8315424 . View Article PubMed/NCBI Google Scholar 14. Stacchiotti S, Dagrada GP, Sanfilippo R, Negri T, Vittimberga I, Ferrari S, et al. Anthracycline-based chemotherapy in ...

WebSep 12, 2016 · J Clin Oncol 11: 1269-1275, 1993 Link, Google Scholar 7. Antman K , Crowley J , Balcerzak SP , et al: An intergroup phase III randomized study of doxorubicin and … WebName: Sharon D Jones, Phone number: (980) 207-1269, State: NC, City: Charlotte, Zip Code: 28215 and more information

WebApr 20, 2024 · J Clin Oncol. 1993;11:1276–1285. 4. Adjuvant chemotherapy for localized resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Sarcoma Meta …

WebJournal of Clinical Oncology; JCO Oncology Practice; JCO Global Oncology; JCO Clinical Cancer Informatics; ... Issue 12 April 20 2024 (pp. 1269-1379) ... Issue 11 November 1 1999 (pp. 3367-3693) ... global coach conference 2023WebJ Clin Oncol 11: 1269–1275, 1993. PubMed CAS Google Scholar Santoro A, Tursz T, Mouridsen H, et al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: A randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma … global coalition against isisWebJ Clin Oncol 2002;20(3):791–6; with permission.) Retrospective studies of pediatric NRSTS have identified a similar group of important prognostic factors, including localized versus metastatic disease, extent of tumor resection, maximal tumor diameter, and tumor grade. ... J Clin Oncol. 1993; 11 (7):1269–75. [Google Scholar] 32. boeing executives delay us wirelessWebApr 18, 2007 · Single-agent gemcitabine and vinorelbine have activity in treatment of patients with soft-tissue sarcomas. The combination of gemcitabine plus vinorelbine has … boeing executive fleetWebSep 12, 2016 · J Clin Oncol 11: 1269-1275, 1993 Link, Google Scholar: 7. Antman K, Crowley J, Balcerzak SP, et al: An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol 11: 1276-1285, 1993 Link, Google Scholar: 8. global coaching ethicsWebFeb 22, 2024 · J Clin Oncol. 1993;11(7):1269-1275. Crossref. PubMed. ISI. Google Scholar. 39. Kienle GS, Grugel R, Kiene H. Safety of higher dosages of Viscum album L. in animals and humans - systematic review of immune changes and safety parameters. BMC Complement Altern Med. 2011;11(1):72. Crossref. global coalition against daeshWebOct 22, 2003 · In a subgroup analysis of patients with leiomyosarcoma histology, there was an objective response rate of 18% (2 of 11 patients), with disease stabilization occurring … boeing executives jobs